James Collins

James Collins combines expertise in engineering, physics, and biology to design and build synthetic gene networks for applications in biotechnology and medicine and to reverse engineer the endogenous gene networks in bacteria that regulate their responses to antibiotics.

At Boston University, Jim is a William F. Warren Distinguished Professor, a University Professor, Professor of Biomedical Engineering, Co-Director and Co-Founder of the Center for BioDynamics, and Co-Director of the Center for Advanced Biotechnology. In 2008, he became the first Boston University faculty member to become a Howard Hughes Medical Institute Investigator.

His many awards include a MacArthur "Genius Award," a National Institutes of Health Director's Pioneer Award, and the Lagrange-CRT Foundation Prize. He has been named to the Technology Review list of top 100 young innovators and the Scientific American list of top 50 outstanding leaders in science and technology. He co-chairs the Scientific Advisory Board (SAB) of Gene Network Sciences, and serves on the SAB of Joule Unlimited, Novophage, LifeWave Ltd, Ensof, and Synereca Pharmaceuticals.